Advertisement

Topics

Valent de Mexico Company Profile

12:07 EDT 18th September 2018 | BioPortfolio

Valent de Mexico is subsidiary of Valent U.S.A., a Sumitomo Chemical Company. With 20 years in the market, Valent de Mexico was the first company within the Mexican Crop Protection Industry to incorporate conventional and biorational proprietary products into their own portfolio. Valent de Mexico is well recognized for working closely with end users and distribution, offering integrated solutions as specialized products with strong field support for Crop Protection and Crop Production needs by the Mexican growers. VdM is headquartered in Guadalajara, Jalisco, Mexico and have Sales and Technical service personnel nationwide. The company web site is www.valent.mx


News Articles [181 Associated News Articles listed on BioPortfolio]

Pneumococcal vaccine effective in RA, Sjögren's syndrome without DMARD treatment

Thirteen-valent pneumococcal conjugate vaccine is immunogenic among patients with rheumatoid arthritis and Sjögren’s syndrome who have not been treated with disease modifying anti-rheumatic drugs, ...

13-Valent Pneumococcal Vaccine Improves Protection Against Acute Otitis Media

The 13-valent pneumococcal conjugate vaccine (PCV13) offers better protection than its predecessor, PCV7, against acute otitis media caused by Streptococcus pneumoniae, according to an...

[Comment] The changing epidemiology of pneumococcal diseases

Substantial decreases in paediatric invasive pneumococcal disease (IPD) have been reported from countries where the 13-valent pneumococcal conjugate vaccine (PCV13) has been introduced for routine use...

[Correspondence] Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?

Pneumococcal vaccination is the cornerstone in the prevention of invasive pneumococcal disease. The use of the first pneumococcal conjugate vaccine in children, the 7-valent pneumococcal conjugate vac...

FDA Grants Priority Review to Merck’s sBLA for Gardasil 9 for Prevention of HPV-Related Cancers and Diseases

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for revi...

Members of migrant caravan protest in Mexico City

MEXICO CITY (AP) — Central American immigrants traveling through Mexico in a caravan that drew the attention of President Donald Trump protested in front of the U.S. Embassy on Saturday in Mexico Ci...

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for GARDASIL 9

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Appli...

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Revision: 30, Authorised

PubMed Articles [440 Associated PubMed Articles listed on BioPortfolio]

Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico.

Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal c...

Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada.

Pneumococcal conjugate vaccines (PCVs) have been available in Canada since 2001, with 13-valent PCV (PCV13) added to the infant routine immunization program throughout all Canadian provinces by 2011. ...

Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis.

This population-based cohort study assesses the impact of switching from a 7-valent pneumococcal conjugate vaccine (PCV) to a 10-valent PCV on outpatient antibiotic use in Dutch infants, and whether g...

Knowledge and use of nutrient labelling of industrialized foods and beverages in Mexico.

To keep record of the knowledge and use of information of the different food labels on industrialized products in Mexico.

Prevalence of sleep symptoms and risk of obstructive sleep apnea in Mexico.

To estimate the prevalence of sleep related symptoms (SRS) in Mexico, and their distribution by region, urbanization and gender.

Clinical Trials [244 Associated Clinical Trials listed on BioPortfolio]

7-valent Pneumococcal Conjugated Vaccination

Hypothesis: the efficacy of 2 doses 7-valent PCV is equivalent to 1 dose 7-valent PCV.

Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomita...

Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomita...

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine Administered to Infants in Korea

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC), relative to a 7-valent pneumococcal conjugate va...

Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomita...

Companies [236 Associated Companies listed on BioPortfolio]

Valent de Mexico

Valent de Mexico is subsidiary of Valent U.S.A., a Sumitomo Chemical Company. With 20 years in the market, Valent de Mexico was the first company within the Mexican Crop Protectio...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

ValueOptions(R) New Mexico

ValueOptions(R) New Mexico is the statewide entity that manages public funding and delivery of care for behavioral health in New Mexico. The organization is committed to providing behavioral healt...

New Mexico Software, Inc.

New Mexico Software, Inc. develops and provides medical IT services and solutions that enable improved and faster communication within the preventative, comprehensive and c...

University of New Mexico Alumni Association

From the Alumni Center at Hodgin Hall, the Alumni Association and Alumni Relations Office keep the University of New Mexico and its alumni communicating and connected.Everyone who graduates from UNM i...

More Information about "Valent de Mexico" on BioPortfolio

We have published hundreds of Valent de Mexico news stories on BioPortfolio along with dozens of Valent de Mexico Clinical Trials and PubMed Articles about Valent de Mexico for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Valent de Mexico Companies in our database. You can also find out about relevant Valent de Mexico Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record